Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2018 2
2019 1
2020 1
2021 1
2022 8
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant.
Phoolcharoen W, Shanmugaraj B, Khorattanakulchai N, Sunyakumthorn P, Pichyangkul S, Taepavarapruk P, Praserthsee W, Malaivijitnond S, Manopwisedjaroen S, Thitithanyanont A, Srisutthisamphan K, Jongkaewwattana A, Tomai M, Fox CB, Taychakhoonavudh S. Phoolcharoen W, et al. Among authors: srisutthisamphan k. Vaccine. 2023 Apr 24;41(17):2781-2792. doi: 10.1016/j.vaccine.2023.03.027. Epub 2023 Mar 21. Vaccine. 2023. PMID: 36963999 Free PMC article.
Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations.
Niyomnaitham S, Atakulreka S, Wongprompitak P, Copeland KK, Toh ZQ, Licciardi PV, Srisutthisamphan K, Jansarikit L, Chokephaibulkit K. Niyomnaitham S, et al. Among authors: srisutthisamphan k. Front Immunol. 2023 Jan 17;13:1080791. doi: 10.3389/fimmu.2022.1080791. eCollection 2022. Front Immunol. 2023. PMID: 36733395 Free PMC article. Clinical Trial.
Hsp90 interacts with multiple dengue virus 2 proteins.
Srisutthisamphan K, Jirakanwisal K, Ramphan S, Tongluan N, Kuadkitkan A, Smith DR. Srisutthisamphan K, et al. Sci Rep. 2018 Mar 9;8(1):4308. doi: 10.1038/s41598-018-22639-5. Sci Rep. 2018. PMID: 29523827 Free PMC article.
Human BST2 inhibits rabies virus release independently of cysteine-linked dimerization and asparagine-linked glycosylation.
Tanwattana N, Wanasen N, Jantraphakorn Y, Srisutthisamphan K, Chailungkarn T, Boonrungsiman S, Lumlertdacha B, Lekchareonsuk P, Kaewborisuth C. Tanwattana N, et al. Among authors: srisutthisamphan k. PLoS One. 2023 Nov 3;18(11):e0292833. doi: 10.1371/journal.pone.0292833. eCollection 2023. PLoS One. 2023. PMID: 37922253 Free PMC article.
Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice.
Kaewborisuth C, Wanitchang A, Koonpaew S, Srisutthisamphan K, Saenboonrueng J, Im-Erbsin R, Inthawong M, Sunyakumthorn P, Thaweerattanasinp T, Tanwattana N, Jantraphakorn Y, Reed MC, Lugo-Roman LA, Hunsawong T, Klungthong C, Jones AR, Fernandez S, Teeravechyan S, Lombardini ED, Jongkaewwattana A. Kaewborisuth C, et al. Among authors: srisutthisamphan k. Vaccines (Basel). 2022 May 16;10(5):786. doi: 10.3390/vaccines10050786. Vaccines (Basel). 2022. PMID: 35632541 Free PMC article.
Pseudotyped zoonotic thogotoviruses exhibit broad entry range in mammalian cells.
Thamamongood T, Jengarn J, Muangsanit P, Petpiroon N, Srisutthisamphan K, Attasombat K, Wongwanakul R, Aueviriyavit S, Laohathai S, Jongkaewwattana A, Teeravechyan S. Thamamongood T, et al. Among authors: srisutthisamphan k. Virology. 2024 Jan;589:109914. doi: 10.1016/j.virol.2023.109914. Epub 2023 Oct 28. Virology. 2024. PMID: 37931589
Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial.
Niyomnaitham S, Toh ZQ, Licciardi PV, Wongprompitak P, Srisutthisamphan K, Copeland KK, Chokephaibulkit K. Niyomnaitham S, et al. Among authors: srisutthisamphan k. J Infect. 2022 Oct;85(4):436-480. doi: 10.1016/j.jinf.2022.06.014. Epub 2022 Jun 18. J Infect. 2022. PMID: 35728642 Free PMC article. Clinical Trial. No abstract available.
Receptor binding domain proteins of SARS-CoV-2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern.
Khorattanakulchai N, Manopwisedjaroen S, Rattanapisit K, Panapitakkul C, Kemthong T, Suttisan N, Srisutthisamphan K, Malaivijitnond S, Thitithanyanont A, Jongkaewwattana A, Shanmugaraj B, Phoolcharoen W. Khorattanakulchai N, et al. Among authors: srisutthisamphan k. J Med Virol. 2022 Sep;94(9):4265-4276. doi: 10.1002/jmv.27881. Epub 2022 Jun 1. J Med Virol. 2022. PMID: 35615895 Free PMC article.
25 results